At Illumina, our corporate responsibility (CR) strategy reflects a bold vision for the future of health—one where unlocking the insights of our cells and genes transforms how we understand biology, deliver care, and improve lives. At the center of this vision is equitable access to genomics, supported by three foundational pillars: